European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Care Payment Schemes by Country

In 2023, Slovenia led European countries in healthcare expenditure on pharmaceuticals and medical non-durable goods via voluntary health care payment schemes with an expense of 98.21 euros per capita, showing a modest increase of 2.91%. While Switzerland, despite a high initial expenditure, saw a decline of 7.26%. Malta exhibited significant growth with an 18.05% increase. Many countries, including France and Liechtenstein, experienced decreases, while Luxembourg and Estonia showed promising growth trends.

Going forward, European nations may see spending shifts due to economic constraints, technological advancements, and healthcare policy changes. Watch for emerging economies adapting voluntary payment schemes and potential increases in personalized and preventive medicine expenditure.